{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T02:25:54Z","timestamp":1770690354534,"version":"3.49.0"},"reference-count":16,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Disseminated cutaneous coccidioidomycosis (DCC) is an uncommon manifestation of Coccidioides infection resulting from hematogenous spread to the skin. While recurrence after treatment discontinuation has been reported in 17 to 50 percent of cases, associated frequency, timing, and risk factors are not well defined. We conducted a retrospective review of biopsy-proven or probable DCC cases between January 2008 and March 2024, and investigated for evidence of recurrence. Demographic, clinical, and treatment data were abstracted, including antifungal regimen, adherence, immune status, and coccidioidal titers. A total of 45 subjects met the inclusion criteria, including 27 immunocompetent and 18 immunosuppressed patients. Eleven (24.4%) experienced one or more recurrences, totaling 22 recurrences; 19 of these (86.4%) occurred at previously affected sites. Ten immunocompetent patients (37.0%) had 21 total recurrences, while one immunosuppressed patient (5.6%) experienced a single recurrence. Median antifungal-free interval before recurrence was 14 months (range, 1\u201396), and 10 recurrences (90.9%) occurred while off antifungal therapy. Ten patients underwent initial surgical excision, with four (40.0%) experiencing a total of 11 recurrences afterwards. DCC recurrence was common, mostly among immunocompetent individuals not on suppressive antifungal therapy, and frequently presented with multiple recurrences. Recurrences were almost always at prior lesion sites, often years after treatment discontinuation.<\/jats:p>","DOI":"10.3390\/jof12020120","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T08:15:54Z","timestamp":1770624954000},"page":"120","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Frequency, Timing, and Patient Factors Associated with Recurrence of Disseminated Cutaneous Coccidioidomycosis"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6735-4522","authenticated-orcid":false,"given":"Nathan A.","family":"Chow","sequence":"first","affiliation":[{"name":"Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ 85259, USA"},{"name":"Mayo Clinic School of Graduate Medical Education, Scottsdale, AZ 85259, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2267-1473","authenticated-orcid":false,"given":"Janis E.","family":"Blair","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ 85259, USA"},{"name":"Division of Infectious Diseases, Mayo Clinic, Phoenix, AZ 85054, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1093\/cid\/ciw360","article-title":"Show more 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis","volume":"63","author":"Galgiani","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_2","unstructured":"Centers for Disease Control and Prevention (CDC) (2025, February 24). Reported Cases of Valley Fever. Valley Fever (Coccidioidomycosis), 23 September 2024, Available online: https:\/\/www.cdc.gov\/valley-fever\/php\/statistics\/index.html."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1590\/abd1806-4841.20153805","article-title":"Coccidioidomycosis and the skin: A comprehensive review","volume":"90","author":"Garcia","year":"2015","journal-title":"An. Bras. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1029\/2019GH000209","article-title":"Expansion of Coccidioidomycosis Endemic Regions in the United States in Response to Climate Change","volume":"3","author":"Gorris","year":"2019","journal-title":"GeoHealth"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Duarte-Escalante, E., del Reyes-Montes, M.R., Fr\u00edas-De-Le\u00f3n, M.G., and Meraz-R\u00edos, B. (2022). Effect of Climate Change on the Incidence and Geographical Distribution of Coccidioidomycosis, Springer International Publishing.","DOI":"10.1007\/978-3-030-89664-5_8"},{"key":"ref_6","first-page":"185","article-title":"Coccidioidomycosis: Epidemiology","volume":"5","author":"Brown","year":"2013","journal-title":"Clin. Epidemiol."},{"key":"ref_7","first-page":"653","article-title":"Coccidioidomycosis: A study of 95 cases of the disseminated type with special reference to the pathogenesis of the disease","volume":"99","author":"Forbus","year":"1946","journal-title":"Mil. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1196\/annals.1406.010","article-title":"State-of-the-art treatment of coccidioidomycosis: Skin and soft-tissue infections","volume":"1111","author":"Blair","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1086\/516115","article-title":"Prediction of relapse after treatment of coccidioidomycosis","volume":"25","author":"Oldfield","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","first-page":"13","article-title":"Association between facial cutaneous coccidioidomycosis and meningitis","volume":"169","author":"Arsura","year":"1998","journal-title":"West. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e2513572","DOI":"10.1001\/jamanetworkopen.2025.13572","article-title":"Estimated Burden of Coccidioidomycosis","volume":"8","author":"Williams","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_12","first-page":"149","article-title":"Recurrence of sarcoid granulomas in lung transplant recipients is common and does not affect overall survival","volume":"31","author":"Schultz","year":"2014","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e175264","DOI":"10.1172\/JCI175264","article-title":"Immune mechanisms of granuloma formation in sarcoidosis and tuberculosis","volume":"134","author":"Weeratunga","year":"2024","journal-title":"J. Clin. Investig."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Angulo, D.A., Alexander, B., Rautemaa-Richardson, R., Alastruey-Izquierdo, A., Hoenigl, M., Ibrahim, A.S., Ghannoum, M.A., King, T.R., Azie, N.E., and Walsh, T.J. (2022). Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections. J. Fungi, 8.","DOI":"10.3390\/jof8111121"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S1473-3099(25)00224-5","article-title":"Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: A single-arm, open-label, phase 2b study","volume":"25","author":"Maertens","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1093\/cid\/ciaf185","article-title":"Fosmanogepix for the Treatment of Invasive Mold Diseases Caused by Aspergillus Species and Rare Molds: A Phase 2, Open-Label Study (AEGIS)","volume":"81","author":"Hodges","year":"2025","journal-title":"Clin. Infect. Dis."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/12\/2\/120\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T08:49:33Z","timestamp":1770626973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/12\/2\/120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["jof12020120"],"URL":"https:\/\/doi.org\/10.3390\/jof12020120","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]}}}